IRIS Accounts Production v25.2.0.378 SC715676 director 1.12.23 30.11.24 30.11.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC7156762023-11-30SC7156762024-11-30SC7156762023-12-012024-11-30SC7156762022-11-30SC7156762022-12-012023-11-30SC7156762023-11-30SC715676ns15:Scotland2023-12-012024-11-30SC715676ns14:PoundSterling2023-12-012024-11-30SC715676ns10:Director12023-12-012024-11-30SC715676ns10:PrivateLimitedCompanyLtd2023-12-012024-11-30SC715676ns10:SmallEntities2023-12-012024-11-30SC715676ns10:AuditExempt-NoAccountantsReport2023-12-012024-11-30SC715676ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-30SC715676ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-30SC715676ns10:FullAccounts2023-12-012024-11-30SC715676ns10:RegisteredOffice2023-12-012024-11-30SC715676ns5:CurrentFinancialInstruments2024-11-30SC715676ns5:CurrentFinancialInstruments2023-11-30SC715676ns5:ShareCapital2024-11-30SC715676ns5:ShareCapital2023-11-30SC715676ns5:RetainedEarningsAccumulatedLosses2024-11-30SC715676ns5:RetainedEarningsAccumulatedLosses2023-11-30SC715676ns5:PlantMachinery2023-12-012024-11-30SC715676ns5:PlantMachinery2023-11-30SC715676ns5:PlantMachinery2024-11-30SC715676ns5:PlantMachinery2023-11-30SC715676ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-30SC715676ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-30
REGISTERED NUMBER: SC715676 (Scotland)















Unaudited Financial Statements for the Year Ended 30 November 2024

for

Rbpharma Ltd

Rbpharma Ltd (Registered number: SC715676)






Contents of the Financial Statements
for the Year Ended 30 November 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Rbpharma Ltd

Company Information
for the Year Ended 30 November 2024







DIRECTOR: Mr R Bentley





REGISTERED OFFICE: 24 Alderley Way
Cumbernauld
Lanarkshire
G68 0GU





REGISTERED NUMBER: SC715676 (Scotland)





ACCOUNTANTS: Greg Hannah Ltd
Chartered Accountants
26 Victoria Street
Rutherglen
Glasgow
G73 1DS

Rbpharma Ltd (Registered number: SC715676)

Balance Sheet
30 November 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 675 984

CURRENT ASSETS
Debtors 6 1,204 49
Cash at bank 22,218 25,516
23,422 25,565
CREDITORS
Amounts falling due within one year 7 23,778 23,670
NET CURRENT (LIABILITIES)/ASSETS (356 ) 1,895
TOTAL ASSETS LESS CURRENT
LIABILITIES

319

2,879

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 219 2,779
319 2,879

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 18 August 2025 and were signed by:





Mr R Bentley - Director


Rbpharma Ltd (Registered number: SC715676)

Notes to the Financial Statements
for the Year Ended 30 November 2024

1. STATUTORY INFORMATION

Rbpharma Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. There were no material departures from that standard.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is derived from pharmaceutical services supplied by the company.

Turnover is measured at the fair value of the service supplied, net of discounts and is recognised at the point that the company obtains right to the consideration.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost

Taxation
Taxation for the year comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
The directors are satisfied that the Company will have access to sufficient funds to ensure that all liabilities will be met as they fall due over a period of at least 12 months from the approval date of these financial statements. Consequently, the directors consider it appropriate to prepare the financial statements on a going concern basis.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 2 ) .

Rbpharma Ltd (Registered number: SC715676)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 December 2023
and 30 November 2024 1,238
DEPRECIATION
At 1 December 2023 254
Charge for year 309
At 30 November 2024 563
NET BOOK VALUE
At 30 November 2024 675
At 30 November 2023 984

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 1,204 49

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 13,601 16,353
Other creditors 10,177 7,317
23,778 23,670

8. RELATED PARTY DISCLOSURES

At the 30th November 2024, the company owed Mr R Bentley (Director) £10,177 (2023 £7,317). Miss K Morris (Shareholder) owed the company £1,204 (2023 £49). The loan owed by Miss K Morris was repaid in full in May 2025.

These above loans are interest free and have no fixed repayment terms.